Table 4 Summary of published studies on status epilepticus cases caused by brain tumors and metastases
Author | Year | Study design | Setting | Study period | SE type | Tumor type | Patients (N) | Age (median) | Male | In-hospital mortality | 30d mort | RSE/SRSE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current study: Rickel | 2024 | Retrospective | Multicenter | 2011–2017 | SE | Brain tumors and metastases | 208 | 62 | 51% | 17.3% | 24% | 54.3% |
Kaneoka | 2023 | Retrospective | Single center | 2013–2019 | NCSE | Gliomas | 5 | 57** | 58.3% | – | – | – |
Vilaseca-Jolonch | 2020 | Prospective, observational | Single center | 2011–2019 | SE | Brain tumors | 82 | 61.6 | 58.5% | 17.1% | – | 52.5% |
Giovannini | 2019 | Prospective, observational | Single center | 2013–2019 | SE | Gliomas | 26 | 68 | 58% | – | 4% | 12% |
Fox | 2019 | Retrospective | Single center | 2006–2018 | SE | Brain metastasis | 19 | 63.9** | 47.4% | 5.3% | 31.6% | 57.9% |
Knudsen-Baas | 2016 | Prospective, observational | Multicenter | 2008–2014 | SE | Gliomas | 20 | 55 | 80% | 0% | 30% | 26% |
Goonawardena | 2015 | Review | – | 1955–2013 | SE | Brain tumors | – | – | – | – | 12–50% | 12–18% |
Marcuse | 2014 | Retrospective | Single center | 2009–2012 | NCSE | Brain tumors | 24 | 62** | 50-% | 0% | 48% *** | – |
Arik | 2014 | Review (14 sudies*) |  | 1994–2009 | SE | Brain tumors | 417 | – |  | 17.2% |  | – |
Cavaliere | 2006 | Retrospective | Single center | 1995–2002 | SE | Brain tumors | 35 | 58 | 65.7% | – | 23% | – |